{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T17:21:22Z","timestamp":1788456082104,"version":"build-2803163510"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T00:00:00Z","timestamp":1586217600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n<jats:title>Background<\/jats:title>\n<jats:p>Aceruloplasminaemia is a very rare autosomal recessive disorder caused by a mutation in the ceruloplasmin gene, which is clinically manifested by damage to the nervous system and retinal degeneration. This classical clinical picture can be preceded by diabetes mellitus and microcytic anaemia, which are considered to be early manifestations of aceruloplasminaemia.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Case presentation<\/jats:title>\n<jats:p>In our report, we describe the case of a patient with aceruloplasminaemia detected in an early stage (without clinical symptoms of damage to the nervous system) during the search for the cause of hepatopathy with very low values of serum ceruloplasmin.<\/jats:p>\n<jats:p>Molecular genetic examination of the CP gene for ceruloplasmin identified a new variant c.1664G\u2009&gt;\u2009A (p.Gly555Glu) in the homozygous state, which has not been published in the literature or population frequency databases to date. Throughout the 21-month duration of chelatase treatment, the patient, who is 43\u2009years old, continues to be without neurological and psychiatric symptomatology. We observed a decrease in the serum concentration of ferritin without a reduction in iron deposits in the brain on magnetic resonance imaging.<\/jats:p>\n<\/jats:sec><jats:sec>\n<jats:title>Conclusion<\/jats:title>\n<jats:p>Currently, there is no unequivocal recommendation of an effective treatment for aceruloplasminaemia. Early diagnosis is important in the neurologically asymptomatic stage.<\/jats:p>\n<\/jats:sec>","DOI":"10.1186\/s12876-020-01237-8","type":"journal-article","created":{"date-parts":[[2020,4,7]],"date-time":"2020-04-07T11:03:33Z","timestamp":1586257413000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["New mutation of the ceruloplasmin gene in the case of a neurologically asymptomatic patient with microcytic anaemia, obesity and supposed Wilson\u2019s disease"],"prefix":"10.1186","volume":"20","author":[{"given":"M\u00e1ria","family":"Ondrejkovi\u010dov\u00e1","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Dra\u017eilov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Drakulov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan L\u00f3pez","family":"Siles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e1ta","family":"Zemjarov\u00e1 Mezensk\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Jungov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fabi\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Rychl\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miroslav","family":"\u017digrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,4,7]]},"reference":[{"key":"1237_CR1","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/neup.12149","volume":"35","author":"H Miyajima","year":"2015","unstructured":"Miyajima H. Aceruloplasminemia. Neuropathology. 2015;35:83\u201390.","journal-title":"Neuropathology"},{"key":"1237_CR2","first-page":"143","volume-title":"Essentials of immunology and serology","author":"J Stanley","year":"2002","unstructured":"Stanley J, et al. Essentials of immunology and serology, vol. 2002. Florence: Thomson Delmar Learning; 2002. p. 143\u20134. ISBN 0-7668-1064-X."},{"key":"1237_CR3","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1073\/pnas.81.2.390","volume":"81","author":"N Takahashi","year":"1984","unstructured":"Takahashi N, Ortel TL, Putnam FW. Single-chain structure of human ceruloplasmin: the complete amino acid sequence of the whole molecule. Proc Natl Acad Sci U S A. 1984;81:390\u20134.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1237_CR4","doi-asserted-by":"publisher","first-page":"3257","DOI":"10.1073\/pnas.83.10.3257","volume":"83","author":"F Yang","year":"1986","unstructured":"Yang F, Naylor SL, Lum JB, Cutshaw S, McCombs JL, Naberhaus KH, et al. Characterization, mappiong, and expression of the human ceruloplasmin gene. Proc Natl Acad Sci U S A. 1986;83:3257\u201361.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1237_CR5","doi-asserted-by":"crossref","first-page":"10780","DOI":"10.1016\/S0021-9258(18)87015-6","volume":"265","author":"F Yang","year":"1990","unstructured":"Yang F, Friedrichs WE, Cupples RL, Bonifacio MJ, Sanford JA, Horton WA, et al. J Biol Chem. 1990;265:10780\u20135.","journal-title":"J Biol Chem"},{"key":"1237_CR6","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1146\/annurev.nutr.22.012502.114457","volume":"22","author":"NE Hellman","year":"2002","unstructured":"Hellman NE, Gitlin JD. Ceruloplasmin metabolism and function. Annu Rev Nutr. 2002;22:439\u201358.","journal-title":"Annu Rev Nutr"},{"key":"1237_CR7","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1038\/nchembio813","volume":"2","author":"S Shiva","year":"2006","unstructured":"Shiva S, Wang X, Ringwood LA, Xu X, Yuditskaya S, Annavajihala V, et al. Ceruloplasmis is a NO oxidase and nitrite synthase that determines endocrine NO homeostasis. Nat Chem Biol. 2006;2:486\u201393.","journal-title":"Nat Chem Biol"},{"key":"1237_CR8","first-page":"968","volume":"2010","author":"S Kono","year":"1802","unstructured":"Kono S, Yoshida K, Tomosugi N, Terada T, Hamaya Y, Kanaoka S, et al. Biological effects of mutant ceruloplasmin on hepicidin-mediated internalization of ferroportin. Biochim Biophys Acta. 1802;2010:968\u201375.","journal-title":"Biochim Biophys Acta"},{"key":"1237_CR9","first-page":"204","volume":"5","author":"G Musci","year":"2014","unstructured":"Musci G, Polticelli F, Bonaccorrsi di Patti MC. Ceruloplasmin-ferroportin system of iron traffic in vertebrates. World J Biol Chem. 2014;5:204\u201315.","journal-title":"World J Biol Chem"},{"key":"1237_CR10","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1016\/j.jhep.2011.11.007","volume":"56","author":"P Ferenci","year":"2012","unstructured":"Ferenci P, et al. EASL clinical practice guidelines: Wilson s disease. J Hepatol. 2012;56:671\u201385.","journal-title":"J Hepatol"},{"key":"1237_CR11","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1097\/MPG.0b013e31827aced4","volume":"56","author":"V Nobili","year":"2013","unstructured":"Nobili V, Siotto M, Bedogni G, et al. Levels of serum ceruloplasmin associate with pediatric nonalcoholic fatty LIver disease. J Pediatr Gastroenterol Nutr. 2013;56:370\u20135.","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"1237_CR12","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13023-017-0757-3","volume":"13","author":"P Vajro","year":"2018","unstructured":"Vajro P, et al. Three unreported cases of TMEM199-CDG, a rare genetic liver disease with abnormal glycosylation. Orphanet J Rare Dis. 2018;13:4. https:\/\/doi.org\/10.1186\/s13023-017-0757-3.","journal-title":"Orphanet J Rare Dis"},{"key":"1237_CR13","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.ajhg.2015.12.011","volume":"98","author":"JC Jansen","year":"2016","unstructured":"Jansen JC, Timal S, van Scherpenzeel M, et al. TMEM199 deficiency is a disorder of golgi homeostasis characterized by elevated aminotransferases, alkaline phosphatase, and cholesterol and abnormal glycosylation. Am J Hum Genet. 2016;98:322\u201332.","journal-title":"Am J Hum Genet"},{"key":"1237_CR14","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1212\/WNL.53.3.617","volume":"3","author":"H Miyajima","year":"1999","unstructured":"Miyajima H, Kohno S, Takahashi Y, Yonekawa O, Kanno T. Estimation of the gene frequency of aceruloplasminemia in Japan. Neurology. 1999;3:617\u20139.","journal-title":"Neurology."},{"key":"1237_CR15","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.parkreldis.2016.12.010","volume":"36","author":"LH Vroegindeweijl","year":"2017","unstructured":"Vroegindeweijl LH, Langendonk JG, Lengeveld M, Hoogendoorn M, Kievit JA, Do Raimondo D, et al. New insights in the neurological phenotype of aceruloplasminemia in Caucasian patients. Parkinsonism Relat Disord. 2017;36:33\u201340.","journal-title":"Parkinsonism Relat Disord"},{"key":"1237_CR16","doi-asserted-by":"publisher","unstructured":"Vroegindeweij LH, van der Beek EH, Boon AJ, Hoogendoorn M, Kievit JA, Wilson JH, et al. Aceruloplasminemia presents as type 1 diabetes in non-obese adults: a detailed case series. Diabet Med. 2015. https:\/\/doi.org\/10.1111\/dme.12712.","DOI":"10.1111\/dme.12712"},{"key":"1237_CR17","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.parkreldis.2018.02.036","volume":"51","author":"S Pelucchi","year":"2018","unstructured":"Pelucchi S, Mariani R, Ravasi G, Pelloni L, Marano M, Tremolizzo L, et al. Phenotypic heterogenity in seven Italian cases aceruloplasminemia. Parkinsonism Relat Disord. 2018;51:36\u201342.","journal-title":"Parkinsonism Relat Disord"},{"key":"1237_CR18","doi-asserted-by":"publisher","unstructured":"Marchi G, Busti F, Zidanes AL, Castagna A, Girelli D. Aceruloplasminemia: a severe neurodegenerative disorder deserving an early diagnosis. Front Neurosci. 2019. https:\/\/doi.org\/10.3389\/fnins.2019.00325.","DOI":"10.3389\/fnins.2019.00325"},{"key":"1237_CR19","doi-asserted-by":"publisher","unstructured":"Parks NE, Vandorpe RA, Moeller JJ. Teaching neuroimages: neurodegeneration with brain iron accumulation in aceruloplasminemia. Neurology. 2013. https:\/\/doi.org\/10.1212\/01.wnl.0000435557.21319.ad.","DOI":"10.1212\/01.wnl.0000435557.21319.ad"},{"key":"1237_CR20","first-page":"1","volume":"131","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Philips A, Cooper DN. The human gene mutation database: a building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Gene Ther. 2014;131:1\u20139.","journal-title":"Hum Gene Ther"},{"key":"1237_CR21","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1093\/nar\/gkv1222","volume":"44","author":"MJ Landrum","year":"2016","unstructured":"Landrum MJ, Lee JM, Bensom M, Brown G, Chao C, Chitipiralla S, et al. ClinVar: public archive of interpretations of clinically relevant variants. Nucleic Acids Res. 2016;44:862\u20138.","journal-title":"Nucleic Acids Res"},{"key":"1237_CR22","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1093\/nar\/gkh131","volume":"32","author":"R Apweiler","year":"2004","unstructured":"Apweiler R, Bairoch A, Wu CH, Barker WC, Boeckmann B, Ferro S, et al. UniProt: the universal protein knowledgebase. Nucleic Acids Res. 2004;32:115\u20139.","journal-title":"Nucleic Acids Res"},{"key":"1237_CR23","doi-asserted-by":"publisher","unstructured":"Piperno A, Alessio M. Aceruloplasminemia: waiting for an efficient therapy. Front Neurosci. 2018. https:\/\/doi.org\/10.3389\/fnins.2018.00903.","DOI":"10.3389\/fnins.2018.00903"},{"key":"1237_CR24","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.1016\/j.jhep.2010.04.039","volume":"53","author":"A Finkenstedt","year":"2010","unstructured":"Finkenstedt A, Wolf E, Hofner E, Gasser BL, Bosch S, Bakry R, et al. Hepatic but not brain iron is rapidly chelated by deferasirox in aceruloplasminemia due to a novel gene mutation. J Hepatol. 2010;53:1101\u20137.","journal-title":"J Hepatol"},{"key":"1237_CR25","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1136\/jnnp.2007.120568","volume":"79","author":"FM Skidmore","year":"2008","unstructured":"Skidmore FM, Drago V, Foster P, Schmalfuss IM, Heilman KM, Streiff RR. Aceruloplasminemia with progressive atrophy without brain iron overload: treatment with oral chelation. J Neurol Neurosurg Psychiatry. 2008;79:467\u201370.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1237_CR26","doi-asserted-by":"publisher","unstructured":"Doyle A, Rusli F, Bhathal P. Aceruloplasminaemia: a rare but important cause of iron overload. BMJ Case Rep. 2015. https:\/\/doi.org\/10.1136\/bcr-2014-207541.","DOI":"10.1136\/bcr-2014-207541"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01237-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-020-01237-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-020-01237-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T23:15:37Z","timestamp":1617750937000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-020-01237-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,7]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["1237"],"URL":"https:\/\/doi.org\/10.1186\/s12876-020-01237-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,4,7]]},"assertion":[{"value":"7 December 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 March 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The case report was approved by the ethics committee of the University Hospital in Bratislava. The patient was given standard care. The patient gave the consent to the publication of this case report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor of this journal.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"95"}}